Health Care & Life Sciences » Pharmaceuticals | China Medical System Holdings Ltd.

China Medical System Holdings Ltd. | Mutual Funds

Mutual Funds that own China Medical System Holdings Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Government Pension Fund - Global (The)
54,964,452
2.21%
7,040,880
0.01%
12/31/2017
Stichting Pensioenfonds ABP (Global Equity Portfolio)
22,207,671
0.89%
-2,163,120
0.01%
03/31/2018
Vanguard Emerging Markets Stock Index Fund
19,705,569
0.79%
-140,000
0.04%
07/31/2018
Vanguard Total International Stock Index Fund
17,806,327
0.72%
535,000
0.01%
07/31/2018
Aviva Investors - Emerging Markets Equity Income Fund
15,273,328
0.61%
-2,278,000
1.36%
06/30/2018
Van Eck Emerging Markets Fund
12,617,000
0.51%
1,326,000
1.09%
03/31/2018
Neuberger Berman Invt. Funds Plc - Greater China Equity Fund
12,523,000
0.5%
2,120,000
1.76%
03/29/2018
Columbia Acorn International Fund
11,744,000
0.47%
-5,477,000
0.45%
03/29/2018
iShares Core MSCI Emerging Markets ETF
11,459,000
0.46%
0
0.04%
09/05/2018
LO Funds - Emerging Consumer
11,250,000
0.45%
-500,000
1.57%
04/30/2018

About China Medical System Holdings

View Profile
Address
6/F-8/F, Block B
Shenzhen Guangdong 518052
China
Employees -
Website http://www.cms.net.cn
Updated 07/08/2019
China Medical System Holdings Ltd. engages in the provision of pharmaceutical products and services. The company focuses on the manufacture, marketing, promotion, and sale of drugs. Its products include Plendi, XinHuoSu, Stulln, XiDaKang, YiNuoShu, DanShenTong, Hirudoid, NuoDiKang, Combizym, GanFuLe, Imdur, Parlodel, Lamisil, YinLianQingGan, and MOVICOL.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.